Director and Qualitative Research Lead of the Clinical Outcomes Assessment (COA)/Patient-Reported Outcome (PRO)
Bethesda, United States
Kelly McCarrier is Director and Qualitative Research Lead of the Patient-Reported Outcomes/Clinical Outcomes Assessment Center of Excellence. Entering the HEOR consulting field in 2006, Kelly has over a decade of experience in qualitative and mixed-methods development and evaluation of COA tools.
In his previous role as a Senior Research Scientist at Health Research Associates (HRA), he served as a principal investigator, qualitative interviewer, analyst, and research methodologist on nearly 100 projects to develop and validate PRO instruments across broad spectrum of health conditions. Kelly helped to lead HRA’s instrument-development collaborations with both the Depression and Lung Cancer Working Groups of the PRO Consortium, resulting in the organization’s first two successful FDA qualifications of outcome assessment tools (the Symptoms of Major Depressive Disorder Scale [SMDDS] and the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire [NSCLC-SAQ]).
Dr. McCarrier earned his PhD in Health Services Research from the University of Washington, and his MPH from the University of Arizona. Before beginning his doctoral studies, he served as an evaluation research fellow with the Centers for Disease Control and Prevention (CDC), conducting qualitative research and program evaluation projects within the Division of Tuberculosis Elimination. Kelly is a member of ISOQOL and ISPOR, and has authored recent publications on the use of novel qualitative research techniques and mixed-methods approaches in the development of PRO instruments.